SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-069248
Filing Date
2017-03-03
Accepted
2017-03-03 12:07:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d357966dsc13ga.htm SC 13G/A 32885
  Complete submission text file 0001193125-17-069248.txt   34142
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89517 | Film No.: 17662249
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DON STUART 221 WEST 6TH STREET, SUITE 1300 AUSTIN TX 78701
Business Address
Hoffman Marguerite (Filed by) CIK: 0001676132 (see all company filings)

Type: SC 13G/A